EHRA Premium Access

Prognostic significance of diabetes mellitus in patients with atrial fibrillation

Topic: Pathophysiology and Mechanisms, Other

Congress Presentation

About the speaker

Doctor Andreas Papazoglou

Naval Hospital of Athens, Athens (Greece)
0 follower

5 more presentations in this session

Identification of novel biomarkers for predicting atrial fibrillation outcomes in patients with cardiovascular risk factors

Speaker: Miss A. Khashaba (Birmingham, GB)


Impact of atrial fibrillation pattern on left atrial appendage closure: insights from the prospective LAARGE registry

Speaker: Doctor S. Kany (Cambridge, US)


Sacubitril/valsartan therapy and supraventricular arrhythmias detected through remote monitoring in heart failure patients

Speaker: Associate Professor F. Guerra (Ancona, IT)


RNA-seq profiling of the atrial transcriptome reveals gender-specific patterns and interactions with atrial fibrillation and heart failure

Speaker: Mr D. Balamurali (Maastricht, NL)


Impaired left atrial reservoir and conduit strain in patients with atrial fibrillation and extensive fibrosis

Speaker: Mr L. Hopman (Amsterdam, NL)


Access the full session

Pathophysiology of atrial fibrillation and beyond I

Speakers: Doctor A. Papazoglou, Miss A. Khashaba, Doctor S. Kany, Associate Professor F. Guerra, Mr D. Balamurali...

About the event


EHRA 2021

23 April - 25 April 2021

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb